conclusion : bucindolol is well tolerated in patients with idiopathic dilated cardiomyopathy and congestive heart failure , and therapy for 3 months is associated with improved resting cardiac function , improved heart failure symptoms , and a reduction in venous norepinephrine concentration .
C0018802
congestive heart failure
C0018787
cardiac